PASSAGE BIO, INC. (PASG)

(10% Negative) PASSAGE BIO, INC. (PASG) Announces Delay in frontotemporal dementia (FTD) Trials for granulin Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review